Stocksigma LogoStocksigma Logo

Astec Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 7,202 (-2.3% YoY | -13.8% QoQ) ■ EBITDA: -1,979 (-196.0% YoY | -2871.3% QoQ) ■ EBITDA Margin (%): -27.5 (-1841 bps YoY | -2668 bps QoQ) ■ PAT

Astec Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Astec Lifesciences Ltd · Outcome · 26 Oct 2026, 10:21 pm

Astec Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 7,202 (-2.3% YoY | -13.8% QoQ) ■ EBITDA: -1,979 (-196.0% YoY | -2871.3% QoQ) ■ EBITDA Margin (%): -27.5 (-1841 bps YoY | -2668 bps QoQ) ■ PAT: -3,741 (-53.1% YoY | -99.9% QoQ) ■ EPS (INR): -16.8 (-48.1% YoY | -99.9% QoQ)

Original exchange filing (PDF)

More announcements from Astec Lifesciences Ltd

All Astec Lifesciences Ltd announcements